期刊文献+

中老年人骨科围手术期有关骨代谢指标变化的研究 被引量:3

Changes of bone metabolic markers during orthopaedic perioperative period in people in middle-age or above
全文增补中
导出
摘要 目的观察中老年骨科手术患者围手术期骨代谢变化特点,为临床治疗提供参考。方法随机抽取年龄50岁以上的中老年患者共113例作为研究对象,分别于术前、术后一周测定静脉血中骨钙素(boneγ-carboxyglutamic acid protein,BGP)及I型胶原交联C端肽(C-terminal telopeptides of type I co★agen,CTX)的水平。结果手术后CTX值较术前明显升高(P<0.001),BGP值较术前明显降低(P<0.001)。其中,骨质疏松症患者、骨折患者手术前后CTX值均变化较大;而骨折患者BGP值手术前后差异无统计学显著性(P>0.05),其余病人BGP值较术前明显降低(P<0.01)。结论中老年人在骨科手术前后存在骨代谢的变化,手术后CTX水平较术前升高,提示骨吸收过程活跃;BGP水平较术前降低,提示骨形成过程受到抑制。骨质疏松患者术后CTX升高程度较非骨质疏松患者明显。 Objective To observe the changes of bone metabolic markers of people in middle-age or above during orthopaedic perioperative period.Methods Osteocalcin(OC or BGP),C-terminal telopeptides of typeⅠcollagen (CTX) in serum were measured by ECLIA in 113 patients(23 males and 90 females,52~89 years old).Bone mineral density(BMD) were measured by dual-energy X-ray densitometer before operation.CTX and BGP were compared before and after operation.Results The CTX level was(0.37±0.28) ng/ml preoperatively and was(0.58±0.35 ) ng/ml postoperatively in all patients(P < 0.001 ).The BGP level was(15.72±10.07 ) ng/ml preoperatively and was (13.05±8.11) ng/ml postoperatively in all patients(P <0.001).The CTX level was(0.37±0.27) ng/ml preoperatively and was(0.69±0.38) ng/ml postoperatively in patients with osteoporosis(P < 0.001).The CTX level was (0.38±0.29) ng/ml preoperatively and was(0.49±0.30) ng/ml postoperatively in patients without osteoporosis(P <0.01).The postoperative CTX level changed in osteoporotic patients was more significantly than that in patients without osteoporosis.Conclusion This study shows that the postoperative serum CTX level was higher than preoperative serum CTX level,which shows bone absorption was increased after operation.Compare the BGP level in serum postoperative stage was lower than preoperative stage;the new bone formation was decreased.The postoperative CTX level changed in osteoporotic patients was more significantly than that in patients without osteoporosis.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2009年第A02期99-103,共2页 Chinese Journal Of Osteoporosis And Bone Mineral Research
关键词 骨代谢 生化标志物 围手术期 骨质疏松 骨折 bone metabolism biochemical markers perioperative period osteoporosis fracture
  • 相关文献

参考文献15

  • 1何威,杨力,蔡德鸿.骨形成与吸收过程中的代谢生化标记物[J].中国临床康复,2005,9(42):118-120. 被引量:15
  • 2李平生,韦兴,殷亚昕,唐志雄,彭朝津,张瑾,刘加昌,候晓霞,蔺静,黄志红,欧阳巧洪.骨质疏松症骨代谢生化指标与骨密度测量分析[J].中国骨质疏松杂志,2005,11(1):22-24. 被引量:23
  • 3谈志龙,白人骁,邢国胜,马宝通,孙培德,王莉,薛言.老年人髋部骨折骨代谢生化指标测定[J].中华创伤杂志,2001,17(6):350-352. 被引量:8
  • 4朱汉民.骨代谢实验室诊断进展[J].上海医学检验杂志,2000,15(5):277-280. 被引量:23
  • 5S. W. Veitch,S. C. Findlay,A. J. Hamer,A. Blumsohn,Richard Eastell,B. M. Ingle.Changes in bone mass and bone turnover following tibial shaft fracture[J].Osteoporosis International.2006(3)
  • 6P. D. Delmas,R. Eastell,P. Garnero,M. J. Seibel,J. Stepan.The Use of Biochemical Markers of Bone Turnover in Osteoporosis[J].Osteoporosis International.2000(6)
  • 7H. N. Rosen,A. C. Moses,J. Garber,I. D. Iloputaife,D. S. Ross,S. L. Lee,S. L. Greenspan.Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy[J].Calcified Tissue International.2000(2)
  • 8B. M. Ingle,S. M. Hay,H. M. Bottjer,R. Eastell.Changes in Bone Mass and Bone Turnover Following Distal Forearm Fracture[J].Osteoporosis International.1999(5)
  • 9N. Tsakalakos MD,B. Magiasis,M. Tsekoura,G. Lyritis.The effect of short-term calcitonin administration on biochemical bone markers in patients with acute immobilization following hip fracture[J].Osteoporosis International.1993(6)
  • 10P. Szulc,P.D. Delmas.Biochemical markers of bone turnover in men[].Calcified Tissue International.2001

二级参考文献33

共引文献64

同被引文献59

  • 1夏维波.骨转换生化标志物的检测及临床评价[J].医师进修杂志,2005,28(5):3-6. 被引量:11
  • 2黄柏辉.骨质疏松骨折血清骨钙素和尿脱氧吡啶酚变化的研究[J].中国骨质疏松杂志,2007,13(8):556-558. 被引量:4
  • 3Genant HK,Cooper C,Poor G,et al.Interim report and recommendations of the World Health Organization TaskForce for Osteoporosis[J].Osteoporos Int,1999,10:259-264.
  • 4Weiss M,Ben-Shlomo AB,Hagag P,et al.Reference database for bone speed of sound measurement by a novel quantitative multi-site ultrasound device[J].Osteoporos Int,2000,11:688-696.
  • 5Karsdal MA,Byrjalsen I,Leeming DJ,et al.The effects of oral calcitonin on bone collagen maturation:implications for bone turnover and quality[J].Osteoporos In,2008,19:1355-1361.
  • 6Szulc P,Delmas PD.Biochemical markers of bone turnover in men[J].Calcif Tissue Int,2001,69:229-234.
  • 7Brown JP,Josse RG.2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada[J].CMAJ,2002,167:S1-34.
  • 8Ofluoglu D,Karadag-Saygi E,Canbulat C,et al.Early effect of nasal salmon calcitonin on the bone marker Crosslaps[J].Rheumatol Int.,2006,26:288-291.
  • 9Adachi JD,Bensen WG,Bell MJ,et al.Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosi[J].Br J Rheumatol,1997,36:255-259.
  • 10Kanis JA,Delmas P,Burckhardt P,et al.Guidelines for diagnosis and management of osteoporosis.The European Foundation for Osteoporosis and Bone Disease[J].Osteoporos Int,1997,7:390-406.

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部